Report cover image

Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Publisher GlobalData
Published Nov 28, 2023
Length 96 Pages
SKU # GBDT18393315

Description

Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Structural Heart Occluders under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Structural Heart Occluders under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

96 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Structural Heart Occluders Overview
4 Products under Development
4.1 Structural Heart Occluders - Pipeline Products by Stage of Development
4.2 Structural Heart Occluders - Pipeline Products by Segment
4.3 Structural Heart Occluders - Pipeline Products by Territory
4.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
4.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
4.6 Structural Heart Occluders - Ongoing Clinical Trials
5 Structural Heart Occluders - Pipeline Products under Development by Companies
5.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
5.2 Structural Heart Occluders – Companies Pipeline Products by Stage of Development
6 Structural Heart Occluders Companies and Product Overview
6.1 Abbott Japan Co Ltd Company Overview
6.1.1 Abbott Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.2 Aegis Medical Innovations Inc. Company Overview
6.2.1 Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.3 Aporo Biomedical, Inc. (Inactive) Company Overview
6.3.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.4 Append Medical Company Overview
6.4.1 Append Medical Pipeline Products & Ongoing Clinical Trials Overview
6.5 atHeart Medical Company Overview
6.5.1 atHeart Medical Pipeline Products & Ongoing Clinical Trials Overview
6.6 AuriGen Medical Ltd Company Overview
6.6.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.7 Boston Scientific Corp Company Overview
6.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
6.8 CARAG AG Company Overview
6.8.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
6.9 Cierra, Inc. (Inactive) Company Overview
6.9.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.1 Conformal Medical Inc Company Overview
6.10.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 Cor Habere Corp Company Overview
6.11.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
6.12 Dextera Surgical Inc Company Overview
6.12.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 Endomimetics LLC Company Overview
6.13.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
6.14 Ension, Inc. Company Overview
6.14.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.15 Guangdong Pulse Medical Technology Co Ltd Company Overview
6.15.1 Guangdong Pulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.16 Hangzhou Dinova EP Technology Co Ltd Company Overview
6.16.1 Hangzhou Dinova EP Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.17 Hansen Medical Inc (Inactive) Company Overview
6.17.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.18 Jenscare Scientific Co Ltd Company Overview
6.18.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.19 Laminar Inc Company Overview
6.19.1 Laminar Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
6.20.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
6.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.22 LuSeed Vascular Company Overview
6.22.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
6.23 Mayo Clinic Company Overview
6.23.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
6.24 Medtronic Plc Company Overview
6.24.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
6.25 Micro Interventional Devices, Inc. Company Overview
6.25.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.26 Northwestern University Company Overview
6.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
6.27 Occlutech International AB Company Overview
6.27.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
6.28 SentreHEART Inc Company Overview
6.28.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
6.29 SeptRx, Inc. (Inactive) Company Overview
6.29.1 SeptRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.3 Shanghai Shenqi Medical Technology Co Ltd Company Overview
6.30.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.31 Swissimplant AG Company Overview
6.31.1 Swissimplant AG Pipeline Products & Ongoing Clinical Trials Overview
6.32 The Chaim Sheba Medical Center Company Overview
6.32.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
6.33 University of Minnesota Company Overview
6.33.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
6.34 Vascular Closure Systems Inc Company Overview
6.34.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
6.35 Vascular Concepts Ltd Company Overview
6.35.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.36 W. L. Gore & Associates Inc Company Overview
6.36.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
6.37 Worry Free Beating Company Overview
6.37.1 Worry Free Beating Pipeline Products & Ongoing Clinical Trials Overview
7 Structural Heart Occluders- Recent Developments
7.1 Nov 13, 2023: Jenscare : Simulock Successfully Completes Implantation Surgery for the First Confirmatory Clinical Trial
7.2 Oct 24, 2023: Conformal Medical Announces Compelling One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study
7.3 Oct 17, 2023: The Gore Relief Clinical Study Begins Randomizing Patients to Evaluate PFO Closure for Migraine Headache Relief
7.4 Sep 07, 2023: Boston Scientific’s LAAC device gets FDA approval
7.5 Sep 06, 2023: Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
7.6 May 17, 2023: MicroPort’s LAA closure AnchorMan device achieves primary endpoint from SAFE PROTECT clinical trial, showing very promising results
7.7 Feb 27, 2023: Study demonstrates successful device size selection when assessing left atrial appendage by angiography compared to TEE
7.8 Jan 31, 2023: Conformal Medical announces positive one-year data from its left atrial appendage closure performed under conscious sedation study
7.9 Jan 05, 2023: JSCAI publishes peer-reviewed article highlighting effective performance of conformal medical's Left Atrial Appendage (CLAAS) Device
7.1 Dec 06, 2022: Henry Ford Health to lead first-of-its-kind national trial for innovative heart device
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Structural Heart Occluders - Pipeline Products by Stage of Development
Table 2: Structural Heart Occluders - Pipeline Products by Segment
Table 3: Structural Heart Occluders - Pipeline Products by Territory
Table 4: Structural Heart Occluders - Pipeline Products by Regulatory Path
Table 5: Structural Heart Occluders - Pipeline Products by Estimated Approval Date
Table 6: Structural Heart Occluders - Ongoing Clinical Trials
Table 7: Structural Heart Occluders Companies - Pipeline Products by Stage of Development
Table 8: Structural Heart Occluders – Companies Pipeline Products by Stage of Development
Table 9: Abbott Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 10: AMJ-505 Left Atrial Appendage Occlusion System - Product Status
Table 11: AMJ-505 Left Atrial Appendage Occlusion System - Product Description
Table 12: Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Aegis Sierra Ligation System - Product Status
Table 14: Aegis Sierra Ligation System - Product Description
Table 15: Aegis Medical Innovations Inc. - Ongoing Clinical Trials Overview
Table 16: Aegis Sierra Ligation System - A Single-arm, Open Label, Multi-center Feasibility Study of the Aegis Sierra Ligation System in Left Atrial Appendage Closure in Patients with Atrial Fibrillation
Table 17: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Patent Foramen Ovale Closure Device - Product Status
Table 19: Patent Foramen Ovale Closure Device - Product Description
Table 20: Append Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Appligator - Product Status
Table 22: Appligator - Product Description
Table 23: atHeart Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 24: reSept ASD Occluder - Product Status
Table 25: reSept ASD Occluder - Product Description
Table 26: atHeart Medical - Ongoing Clinical Trials Overview
Table 27: reSept ASD Occluder - Evaluation of the Safety and Efficacy of the reSept ASD Occluder to Treat Patients with Clinically Significant Secundum Atrial Septal Defect
Table 28: AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 29: F Aurigen Delivery System - Product Status
Table 30: F Aurigen Delivery System - Product Description
Table 31: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 32: AnchorMan Left Atrial Appendage Closure - Product Status
Table 33: AnchorMan Left Atrial Appendage Closure - Product Description
Table 34: WATCHMAN FLX Pro - Product Status
Table 35: WATCHMAN FLX Pro - Product Description
Table 36: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Carag BioResorbable Septal Occluder - Product Status
Table 38: Carag BioResorbable Septal Occluder - Product Description
Table 39: CARAG AG - Ongoing Clinical Trials Overview
Table 40: Carag BioResorbable Septal Occluder - Multi Centre, International, Post Market Registry to Monitor the Clinical Performance and Safety of an Atrial Septal Closure Device with Bioresorbable Framework in Patients with Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) in Routine Clinical Use
Table 41: Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 42: PFx Closure System - Product Status
Table 43: PFx Closure System - Product Description
Table 44: Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: CLAAS Device - Product Status
Table 46: CLAAS Device - Product Description
Table 47: Conformal Medical Inc - Ongoing Clinical Trials Overview
Table 48: CLAAS Device - An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion
Table 49: CLAAS Device - The CONFORMAL Early Feasibility Study an Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 50: CLAAS Device - The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 51: CLAAS Device - The Conscious Sedation Single Arm Sub-Study
Table 52: Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 53: StrokeShield System - Product Status
Table 54: StrokeShield System - Product Description
Table 55: Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: PFO Closure Device - Product Status
Table 57: PFO Closure Device - Product Description
Table 58: Dextera Surgical Inc - Ongoing Clinical Trials Overview
Table 59: PFO Closure Device - Effectivity and Safety of PFO Closure Vs Medicine in Alleviating Migraine (SPRING): A Multicenter, Random, Case Control Study
Table 60: Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Atrial Septal Defect Device - Product Status
Table 62: Atrial Septal Defect Device - Product Description
Table 63: Vascular Septal Defect (VSD) Occluder - Product Status
Table 64: Vascular Septal Defect (VSD) Occluder - Product Description
Table 65: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Atrial Septal Defect Correction Device - Product Status
Table 67: Atrial Septal Defect Correction Device - Product Description
Table 68: Guangdong Pulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Patent Foramen Ovale (PFO) Occluder - Product Status
Table 70: Patent Foramen Ovale (PFO) Occluder - Product Description
Table 71: Guangdong Pulse Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 72: Patent Foramen Ovale (PFO) Occluder - Prospective, Multicenter, Single-Group Target Value Method To Evaluate the Safety and Effectiveness of Patent Foramen Ovale Occluder System
Table 73: Hangzhou Dinova EP Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Snowy PFO Closure System - Product Status
Table 75: Snowy PFO Closure System - Product Description
Table 76: Hangzhou Dinova EP Technology Co Ltd - Ongoing Clinical Trials Overview
Table 77: Snowy PFO Closure System - A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Effectiveness of the Snowy PFO Closure System in Plugging Patent Foramen Ovale
Table 78: Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Sensei Robotic Catheter System - LAA - Product Status
Table 80: Sensei Robotic Catheter System - LAA - Product Description
Table 81: Sensei Robotic Catheter System - PFO Closure - Product Status
Table 82: Sensei Robotic Catheter System - PFO Closure - Product Description
Table 83: Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 84: OmniSeal - Product Status
Table 85: OmniSeal - Product Description
Table 86: SimuLock - Product Status
Table 87: SimuLock - Product Description
Table 88: Laminar Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Laminar Left Atrial Appendage Closure System - Product Status
Table 90: Laminar Left Atrial Appendage Closure System - Product Description
Table 91: Laminar Inc - Ongoing Clinical Trials Overview
Table 92: Laminar Left Atrial Appendage Closure System - A European Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects with Non-Valvular Atrial Fibrillation
Table 93: Laminar Left Atrial Appendage Closure System - A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects with Non- Valvular Atrial Fibrillation
Table 94: Laminar Left Atrial Appendage Closure System - An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects with Non-Valvular Atrial Fibrillation
Table 95: Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 96: LAA Closure Occluder II - Product Status
Table 97: LAA Closure Occluder II - Product Description
Table 98: MemoSorb ASD Occluder IV - Product Status 5
Table 99: MemoSorb ASD Occluder IV - Product Description 5
Table 100: MemoSorb PFO Occluder II - Product Status
Table 101: MemoSorb PFO Occluder II - Product Description
Table 102: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 103: LAmbre LAA Closure System - Product Status
Table 104: LAmbre LAA Closure System - Product Description
Table 105: Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
Table 106: LAmbre LAA Closure System - Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF: The CORRAL-AF Study
Table 107: LAmbre LAA Closure System - LAmbre Versus AMPLATZER Amulet Left Atrial Appendage Occluder for Stroke Prophylaxis: The Randomized AMPIRI Trial
Table 108: LAmbre LAA Closure System - LifeTech LAmbre Keft Atrial Appendage (LAA) Closure System Post-market Clinical Follow-up
Table 109: LAmbre LAA Closure System - Lifetech LAmbre Left Atrial Appendage Closure System Post-Market Clinical Follow-up Multi-center, Single-arm, Prospective, Post-market study
Table 110: LAmbre LAA Closure System - Lifetech Lambre Left Atrial Appendage Closure System Post-market Registry Single-center, Single-arm, Prospective, Post-market Registry
Table 111: LAmbre LAA Closure System - Safety and Efficacy Study of LAmbre Plus LAA occluder System in Non-valvular Atrial Fibrillation Patients
Table 112: LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
Table 113: LuSeed Intrasaccular Device - LAA Occlusion - Product Status
Table 114: LuSeed Intrasaccular Device - LAA Occlusion - Product Description
Table 115: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 116: Left Atrial Appendage Closure Device - Product Status
Table 117: Left Atrial Appendage Closure Device - Product Description
Table 118: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Cardioblate Closure LAA Occlusion Device - Product Status
Table 120: Cardioblate Closure LAA Occlusion Device - Product Description
Table 121: Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 5
Table 122: Patent Foramen Ovale Fixation Device - Product Status 5
Table 123: Patent Foramen Ovale Fixation Device - Product Description 5
Table 124: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 6
Table 125: Left Atrial Appendage Occluder - Product Status 6
Table 126: Left Atrial Appendage Occluder - Product Description 6
Table 127: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Occlutech Figulla Flex II ASD Occluder - Product Status
Table 129: Occlutech Figulla Flex II ASD Occluder - Product Description
Table 130: Occlutech Figulla Flex UNI - Product Status
Table 131: Occlutech Figulla Flex UNI - Product Description
Table 132: Occlutech Pistol Pusher - Product Status
Table 133: Occlutech Pistol Pusher - Product Description
Table 134: Occlutech International AB - Ongoing Clinical Trials Overview
Table 135: Occlutech Figulla Flex II ASD Occluder - Comparative Effectiveness of Three Devices for Transcatheter Closure of Atrial Septal Defects for Adults: A Pilot Study (Trio-ASD)
Table 136: Occlutech Figulla Flex II ASD Occluder - MitraClip and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure - Evaluation of Morphologic and Functional Changes in a Randomized Setting
Table 137: Occlutech Figulla Flex II ASD Occluder - Study to Evaluate the Efficacy of Occlutech ASD Occluder in the Treatment of Atrial Septal Defects
Table 138: Occlutech Pistol Pusher - A Registry-based, Multicenter, International, Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices:Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP), Occlutech Sizing Balloon (OSB) Used During to Implantation Procedures of Cardiac Implant Devices
Table 139: SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Eclipse Surgical Left Atrial Appendage Closure Device - Product Status
Table 141: Eclipse Surgical Left Atrial Appendage Closure Device - Product Description
Table 142: LARIAT Suture Delivery Device - Adjunctive Therapy - Product Status
Table 143: LARIAT Suture Delivery Device - Adjunctive Therapy - Product Description
Table 144: SentreHEART Inc - Ongoing Clinical Trials Overview
Table 145: LARIAT Suture Delivery Device - Adjunctive Therapy - Left Atrial Appendage Ligation with the LARIAT Suture Delivery System as Adjunctive Therapy to Pulmonary Vein Isolation for Persistent or Longstanding Persistent Atrial Fibrillation 5
Table 146: LARIAT Suture Delivery Device - Adjunctive Therapy - Non-randomized, Multicenter Expanded Use Evaluation of the LARIAT Suture Delivery Device (Appendix 16 to Ongoing Investigation) 5
Table 147: SeptRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 6
Table 148: SeptRx IPO - Product Status 6
Table 149: SeptRx IPO - Product Description 6
Table 150: Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 7
Table 151: Left Atrial Appendage Occluder System - Product Status 7
Table 152: Left Atrial Appendage Occluder System - Product Description 7
Table 153: Swissimplant AG Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Solysafe Septal Occluder – 10Fr Sheath - Product Status
Table 155: Solysafe Septal Occluder – 10Fr Sheath - Product Description
Table 156: The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 157: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Status
Table 158: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Description
Table 159: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 160: Bioresorbable Occlusion Device - Product Status
Table 161: Bioresorbable Occlusion Device - Product Description
Table 162: Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 163: RF Thermal Closure System - Product Status
Table 164: RF Thermal Closure System - Product Description
Table 165: Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 166: VSD (Ventricular Septal Device) - Product Status
Table 167: VSD (Ventricular Septal Device) - Product Description
Table 168: W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 169: BioTREK - Product Status
Table 170: BioTREK - Product Description
Table 171: Worry Free Beating Pipeline Products & Ongoing Clinical Trials Overview
Table 172: Degradable Occlusion System - Product Status
Table 173: Degradable Occlusion System - Product Description
Table 174: Glossary 5
2.2 List of Figures
Figure 1: Structural Heart Occluders - Pipeline Products by Stage of Development
Figure 2: Structural Heart Occluders - Pipeline Products by Segment
Figure 3: Structural Heart Occluders - Pipeline Products by Territory
Figure 4: Structural Heart Occluders - Pipeline Products by Regulatory Path
Figure 5: Structural Heart Occluders - Pipeline Products by Estimated Approval Date
Figure 6: Structural Heart Occluders - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us